Introduction
The pharmaceutical industry faces numerous challenges in sourcing sustainable and reliable ingredients. Drug shortages pose significant issues for healthcare systems worldwide. These shortages can occur for various reasons, including manufacturing problems, quality issues, supply chain disruptions, regulatory challenges, increased demand, and financial constraints. Shortages of active pharmaceutical ingredients (APIs) and excipients due to supply disruptions can impact the consistent supply of drugs.
This article delves into the efforts and achievements of Lactalis Ingredients Pharma, a division of the global dairy leader Lactalis Group, in providing a sustainable and reliable source of pharmaceutical lactose.
The Lactalis Group: A Global Dairy Leader
Lactalis Group stands as a beacon in the dairy industry:
- 1st Global Dairy Group
- 1st Global Player in the Cheese Market
- €28.3 Billion Sales Revenue
- 270 Production Sites in 52 Countries
Lactalis Ingredients: A Trusted Name in Dairy Ingredients
Lactalis Ingredients is a top-tier leader in dairy ingredients, producing 624,000 tons annually and processing 2.5 billion liters of milk and 5.7 billion liters of whey each year. Serving over 100 countries worldwide, Lactalis Ingredients has established a strong reputation, particularly in lactose production.
Expertise in Lactose Production
With over 50 years of experience, Lactalis Ingredients is renowned for its high technical and industrial expertise. It is trusted by the most demanding markets, including infant and clinical applications, ensuring the highest standards of quality and reliability.
Lactalis Ingredients Pharma: Consistent Supply and Optimal Production
Lactalis Ingredients Pharma benefits from a consistent supply of raw liquid whey sourced from Lactalis Group’s cheese factories, which is the leader of world cheese production. Proximity between the raw whey collection and the production plant ensures efficiency and reliability. Annually, over 180,000 tons of cheese production supplies Retiers with raw liquid whey and permeate.
Lactalis Ingredients Pharma epitomizes reliability and sustainability in pharmaceutical lactose production. The state-of-the-art plant in France adheres to the highest standards, including GMP, Ph. Eur., USP-NF, and JP monographs. The production unit is certified by ISO 9001, FSSC 22000, and EXCiPACT.
Lactalpha: The Flagship Product Line
Lactalpha is Lactalis Ingredients Pharma’s range of milled and sieved lactose monohydrate, designed for various pharmaceutical applications such as wet/dry granulation and dry blending in OSD production. Key features include:
- Available Particle Sizes: 50 mesh, 100 mesh, 150 mesh (200 mesh under development)
- Conformance: Meets the monographs of current Pharmacopoeias (Ph Eur., USP-NF, JP)
Lactalis Ingredients Pharma stands at the forefront of sustainable and reliable pharmaceutical lactose sourcing. With a commitment to quality and sustainability, it meets the stringent demands of the pharmaceutical industry. For more information or to receive a sample, please contact us.
